AS01B
AS01B has been studied in 3 papers since 2021: none in people yet, 2 in animals, 1 review. The research so far is in animals. The newest paper, Dec 1, 2023: “Advances in understanding the mechanism of action of adult vaccines”.
3 papers study itUpdated
At a glance
1 trial, none about aging.
Cells, worms or flies, mice and humans: nothing yet.
- 1 trial, none about aging
- 1 of 1 trial sponsored by its developers
- Animals2
Trial sponsors
Company1 trialPhase 1/2504 people
Latest
The Journal of Clinical Investigation
Advances in understanding the mechanism of action of adult vaccines
CommentaryInterventions
Science Translational Medicine
An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice
Experiments in miceInterventions
bioRxiv
An adjuvanted SARS-CoV-2 RBD nanoparticle elicits neutralizing antibodies and fully protective immunity in aged mice
Preprint: experiments in miceBlood and immune system